K002272 is an FDA 510(k) clearance for the BRANAN MEDICAL CORPORATION MONITECT PCP DRUG SCREEN TEST, MODEL 160C AND 160D. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Branan Medical Corp. (Irvine, US). The FDA issued a Cleared decision on November 22, 2000 after a review of 119 days - within the typical 510(k) review window.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.
View all Branan Medical Corp. devices